| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |